Moreover, RBM4 reduction also elevated the activity of senescence marker, SA-β-gal, in colorectal and liver cancer cell lines (Supplementary Fig. 6j), but not increased p27 expression (Supplementary Fig. 6i), suggesting the underlying mechanism is different from that in ESCC cells. Here, RBM4 is linked to esophageal squamous cell carcinoma.